Cargando…

Association of TP53 codon 72 polymorphism and the outcome of adjuvant therapy in breast cancer patients

INTRODUCTION: Single-nucleotide polymorphisms (SNPs) in codon 72 of the TP53 (also known as p53) gene (rs1042522) and in the promoter region of the MDM2 gene (SNP309; rs2279744) have been suggested to play roles in many cancers. We investigated whether these SNPs were associated with patient outcome...

Descripción completa

Detalles Bibliográficos
Autores principales:	Toyama, Tatsuya, Zhang, Zhenhuan, Nishio, Mariko, Hamaguchi, Maho, Kondo, Naoto, Iwase, Hirotaka, Iwata, Hiroji, Takahashi, Satoru, Yamashita, Hiroko, Fujii, Yoshitaka
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1929098/ https://www.ncbi.nlm.nih.gov/pubmed/17537232 http://dx.doi.org/10.1186/bcr1682

Ejemplares similares

p53 protein accumulation predicts resistance to endocrine therapy and decreased post-relapse survival in metastatic breast cancer
por: Yamashita, Hiroko, et al.
Publicado: (2006)

Phosphorylation of estrogen receptor α serine 167 is predictive of response to endocrine therapy and increases postrelapse survival in metastatic breast cancer
por: Yamashita, Hiroko, et al.
Publicado: (2005)

Coexistence of HER2 over-expression and p53 protein accumulation is a strong prognostic molecular marker in breast cancer
por: Yamashita, Hiroko, et al.
Publicado: (2004)

Frequently increased epidermal growth factor receptor (EGFR) copy numbers and decreased BRCA1 mRNA expression in Japanese triple-negative breast cancers
por: Toyama, Tatsuya, et al.
Publicado: (2008)

Impact of TP53 Codon 72 and MDM2 SNP 309 Polymorphisms in Pancreatic Ductal Adenocarcinoma
por: Hori, Yasuki, et al.
Publicado: (2015)

Association of TP53 gene codon 72 polymorphism with endometriosis risk in Isfahan
por: Nikbakht Dastjerdi, Mehdi, et al.
Publicado: (2013)

Prognostic value genotypes and LOH at TP53 codon 72 and TP53 mutations in primary breast cancer
por: Kyndi, M, et al.
Publicado: (2005)

Analysis of Tp53 Codon 72 Polymorphisms, Tp53 Mutations, and HPV Infection in Cutaneous Squamous Cell Carcinomas
por: Loeb, Keith R., et al.
Publicado: (2012)

TP53 codon 72 polymorphism affects accumulation of mtDNA damage in human cells
por: Altilia, Serena, et al.
Publicado: (2012)

Association of the TP53 codon 72 polymorphism and breast cancer risk: a meta-analysis
por: Gonçalves, Meire Luzia, et al.
Publicado: (2014)

The TP53 Codon 72 Polymorphism and Risk of Sporadic Prostate Cancer among Iranian Patients
por: BABAEI, Farhad, et al.
Publicado: (2014)

Associations of TP53 codon 72 polymorphism with complications and comorbidities in patients with type 1 diabetes
por: Słomiński, Bartosz, et al.
Publicado: (2021)

TP53 codon 72 polymorphism may predict early tumour progression in paediatric pilocytic astrocytoma
por: Mascelli, Samantha, et al.
Publicado: (2016)

Meta-Analysis Results on the Association Between TP53 Codon 72 Polymorphism With the Susceptibility to Oral Cancer
por: Lin, Ying-Mei, et al.
Publicado: (2018)

Quantitative determination, by real-time reverse transcription polymerase chain reaction, of aromatase mRNA in invasive ductal carcinoma of the breast
por: Zhang, Zhenhuan, et al.
Publicado: (2003)

Polymorphisms of TP53 codon 72 with breast carcinoma risk: evidence from 12226 cases and 10782 controls
por: Zhuo, Wenlei, et al.
Publicado: (2009)

TP53 codon 72 Gene Polymorphism Paradox in Associated with Various Carcinoma Incidences, Invasiveness and Chemotherapy Responses
por: Lin, Hung-Yu, et al.
Publicado: (2008)

Correction: Impact of TP53 Codon 72 and MDM2 SNP 309 Polymorphisms in Pancreatic Ductal Adenocarcinoma
Publicado: (2015)

Systematic evaluation of TP53 codon 72 polymorphism associated with onset and progression of oral potentially malignant disorders
por: Li, Huangkai, et al.
Publicado: (2023)

Randomized controlled trial of toremifene 120 mg compared with exemestane 25 mg after prior treatment with a non-steroidal aromatase inhibitor in postmenopausal women with hormone receptor-positive metastatic breast cancer
por: Yamamoto, Yutaka, et al.
Publicado: (2013)

Importance of TP53 codon 72 and intron 3 duplication 16bp polymorphisms in prediction of susceptibility on breast cancer
por: Costa, Sandra, et al.
Publicado: (2008)

Association of DRD4 uVNTR and TP53 codon 72 polymorphisms with schizophrenia: a case-control study
por: Lung, For-Wey, et al.
Publicado: (2009)

The Role of TP53 Gene Codon 72 Polymorphism in Leukemia: A PRISMA-Compliant Systematic Review and Meta-Analysis
por: Ruan, Xiao-Lan, et al.
Publicado: (2015)

TP53 codon 72 polymorphism is associated with FGFR3 and RAS mutation in non-muscle-invasive bladder cancer
por: Kawahara, Takashi, et al.
Publicado: (2019)

Effects of MDM2, MDM4 and TP53 Codon 72 Polymorphisms on Cancer Risk in a Cohort Study of Carriers of TP53 Germline Mutations
por: Fang, Shenying, et al.
Publicado: (2010)

The TP53 Codon 72 Arginine Polymorphism Is Found with Increased TP53 Somatic Mutations in HPV(−) and in an Increased Percentage among HPV(+) Norwegian HNSCC Patients
por: Moe, Svein Erik, et al.
Publicado: (2023)

Ratio of Expression of p16(INK4a) to p14(ARF) Correlates with the Progression of Non‐small Cell Lung Cancer
por: Moriyama, Satoru, et al.
Publicado: (2002)

Loss of heterozygosity at the ATBF1-A locus located in the 16q22 minimal region in breast cancer
por: Kai, Kazuharu, et al.
Publicado: (2008)

Identification of biomarkers in ductal carcinoma in situ of the breast with microinvasion
por: Okumura, Yasuhiro, et al.
Publicado: (2008)

Association between the TP53 codon 72 polymorphism and risk of oral squamous cell carcinoma in Asians: a meta-analysis
por: Zeng, Xian-Tao, et al.
Publicado: (2014)

Influence of TP53 Codon 72 Polymorphism Alone or in Combination with HDM2 SNP309 on Human Infertility and IVF Outcome
por: Chan, Ying, et al.
Publicado: (2016)

Association between TP53 gene codon72 polymorphism and prostate cancer risk: A systematic review and meta-analysis
por: Han, Pei-Zhen, et al.
Publicado: (2019)

TP53 codon 72 Polymorphism and bladder cancer risk: a meta-analysis and emphasis on the role of tumor or smoking status
por: Zhang, Lei, et al.
Publicado: (2018)

Elevated serum expression of p53 and association of TP53 codon 72 polymorphisms with risk of cervical cancer in Bangladeshi women
por: Mostaid, Md Shaki, et al.
Publicado: (2021)

GANP protein encoded on human chromosome 21/mouse chromosome 10 is associated with resistance to mammary tumor development
por: Kuwahara, Kazuhiko, et al.
Publicado: (2016)

Estrogen Receptor, c‐erbB‐2 and nm23/NDP Kinase Expression in the Intraductal and Invasive Components of Human Breast Cancers
por: Kobayashi, Shunzo, et al.
Publicado: (1992)

Association Between TP53 Gene Codon 72 Polymorphism and Acute Myeloid Leukemia Susceptibility: Evidence Based on a Meta-Analysis
por: Ruan, Xiao-Lan, et al.
Publicado: (2015)

Importance of TP53 codon 72 and intron 3 duplication 16 bp polymorphisms and their haplotypes in susceptibility to sarcopenia in Iranian older adults
por: Montazeri-Najafabady, Nima, et al.
Publicado: (2022)

Analysis of Oncogenes and Tumor Suppressor Genes in Human Breast Cancer
por: Yamashita, Hiroko, et al.
Publicado: (1993)

Association of TP53 Codon 72 Arg>Pro Polymorphism with Breast and Lung Cancer Risk in the South Asian Population: A Meta-Analysis
por: Jafrin, Sarah, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6sa565gk27jlsio4galsbr9u1g